Introduction to the NHLBI Context. Agenda  Introduction to the NMDP / CIBMTR  Forms being curated  Progress update  Description of review process.

Slides:



Advertisements
Similar presentations
A Inter Body Killer! It is a white blood cell Destroy infection Is the core to immunity also known as T-lymphocyte They mature in the thymus (part of.
Advertisements

Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.
Introduction to Leukemia
Cancer 101 Monica Schlatter, RN, ND, AOCNP. Types of Cancer AIDS- related malignancies AIDS- related malignancies Bone and soft tissue sarcoma Bone and.
Nursing 210 Fluid and Cells Nursing management of patients with hematologic dysfunction Laurie Brown RN, MSN, MPA-HA, CCRN.
Blood and Marrow Transplant: The basics…what you need to know Resident Education Lecture Series.
Hematopoietic stem cell transplantation
BLOOD TRANSFUSION SUPPORT IN STEM CELL TRANSPLANT
Hematopoietic Stem Cells A hematopoietic stem cell is a cell isolated from the blood or bone marrow that can renew itself, can differentiate to a variety.
18 and Swabbin: Never Too Young. The Delete Blood Cancer Mission Our mission is our name. We work to “Delete Blood Cancer” by inspiring as many people.
Transplantation of hematopoietic stem cells in pediatric oncology Vladivostok State Medical University Foreign languages department Vladivostok 2012 Scientific.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.
What is Leukemia? Leukemia is cancer of the blood. Often times, symptoms of Leukemia go unnoticed or do not appear at all in the early stages. Because.
Shannon N. Barringer, MS Certified Genetic Counselor UAMS Department of OB/GYN ANGELS Program Who Should Bank Their Baby’s Cord Blood?
Educational Presentation. Program Overview Provide information on The Leukemia & Lymphoma Society Describe blood cancers Explain Pennies for Patients.
Brain tumors = leading cause of solid tumor deaths in children Low grade brain tumors = most common NO CURES CURRENT TREATMENT = TOXIC Better treatments.
Building Canada’s National Public Cord Blood Bank.
Cord Blood Donation Its clinical uses and the OB role.
Stages of Development Zygote (from the Greek: ἔ μβρυα, lit. "that which grows”) Morula (16 cell pre- embryo) Blastocyst Embryo.
Stem Cell Research –information for today’s Catholics.
Stem Cells. What are Stem Cells? Stem Cells: Cells that do not yet have a specific function or job in the organism.
Aplastic anemia. Definition Panctopenia with hypocellularity A rare and serious condition, aplastic anemia can develop at any age, though it's most common.
START PROGRAM: STATE-OF-THE-ART ONCOLOGY IN EUROPE RARECARENet kick-off Luxembourg – July 13, 2012 Chairperson: Dr. Lisa Licitra.
STATE HEALTH PLAN REQUEST FOR REVIEW OF DONOR COVERAGE BENEFITS Presented by: S. Elizabeth Sharf August 2015.
Transplant Creations1 Treatment & Transplant Program to improve disease outcome Transplant Creations Marlies Van Hoef.
Total Body Irradiation Nancy J Tarbell, MD. Contents BMT Background/History TBI technique, dose rate and fractionation Acute Effects Late Effects References.
بسم الله الرحمن الرحيم. Leukocytes Leukopenia Leukocytosis.
INTRODUCTION TO PEDIATRIC ONCOLOGY Prof.Dr.Reha Cengizlier
Bone marrow Transplant in Paediatric Haematology
Blood Cancers in older adults Cancer and Older Adults 19 November 2015 Matthew Foster, MD Assistant Professor of Medicine Leukemia, Lymphoma and Myeloma.
Hematology and Hematologic Malignancies
CHAPTER 21 THE GENETIC BASIS OF DEVELOPMENT.
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Total Body Irradiation Nancy J Tarbell, MD. Contents BMT Background/History TBI technique, dose rate and fractionation Acute Effects Late Effects References.
Acute Leukemia Kristine Krafts, M.D..
By: Ashlynn Hill. Patrice Thompson  3 year who is battling leukemia.  The doctors suggest a bone marrow transplants for a long term survival.  Neither.
Haema - Non Mal:1 Shashi: 03/00 Non Malignant WBC - Disorders.
Hematology Block: Overview and Advice Tim Boswell, M4 Presentation created on 3/21/16.
* Cases diagnosed from 1992 to 1995 Childhood and adolescent cancer survival: A period analysis of data from the Canadian Cancer Registry Larry F. Ellison,
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths
Nursing Management: Hematologic Problems Chapter 31 Overview Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
HAPLOIDENTICAL STEM CELL TRANSPLANT
Leukemia Jeff Liu, Period 5.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
Hematopoietic Stem Cell Transplantation (HSCT)
New Approaches for Transplant Patients Linda J Burns, MD Medical Director, Health Services Research Program National Marrow Donor Program (NMDP)/Be the.
Cord Blood Presentation to the AZ House Health Committee Charis Ober Save the Cord Foundation January 12, 2016.
Blood and Marrow Transplant: The basics…what you need to know
Chapter 13 Lesson 13.2 anemia Aplastic anemia Hemolytic anemia Pernicious anemia sickle cell thalassemia Hemochromatosis polycythemia vera Hemophilia purpura.
RIC UCBT Transplantation of Umbilical Cord Blood from Unrelated Donors in Patients with Haematological Diseases using a Reduced Intensity Conditioning.
Acute Leukemia Kristine Krafts, M.D..
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides INTRODUCTION: The Summary Slides are an annual report.
New Issue Released by Journal of Hematology and Blood Disorders
Supplemental table 1 Patients' characteristics Variables Number
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT)
Chronic Leukemia Kristine Krafts, M.D..
LEUKEMIA By: J.U..
In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,
Timing for HCT Consultation
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation,
High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
HIV Update, The OPO’s Perspective
Introduction. Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan.
Intro to Cancer.
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

Introduction to the NHLBI Context

Agenda  Introduction to the NMDP / CIBMTR  Forms being curated  Progress update  Description of review process 2

NMDP  National Marrow Donor Program  Be the Match Registry  World’s largest registry of potential bone marrow / PBSC donors and donated umbilical cord blood units  Matches donors to recipients  Facilitates transplantation from initial search through product delivery

CIBMTR  Center for International Blood and Marrow Transplant Research  Research division of the NMDP  Collects and maintains outcomes data  Conducts clinical trials  Maintains a repository of paired donor and recipient blood samples  Mission is to improve patient outcomes and ensure donor safety

Forms That Have Been Curated  Pre-transplantation  Pre-transplantation diagnosis and treatment  Infectious disease markers  HLA typing  Product collection, storage, transport and infusion  Post-transplantation  Outcome  Annual follow-up  Death 5

Diseases (1 of 2) * Form Builder CRF  * Acute Myelogenous Leukemia (AML)  * Acute Lymphoblastic Leukemia (ALL)  * Chronic Myelogenous Leukemia (CML)  * Chronic Lymphoblastic Leukemia (CLL)  Myelodysplasia / Myeloproliferative Disorders  Multiple Myeloma / Plasma Cell Leukemia  * Amyeloidosis 6

Diseases (1 of 2)  * Hodgkin and Non-Hodgkin Lymphoma  * Breast cancer  * Testicular cancer  * Central nervous system tumors  Neuroblastoma  * Aplastic anemia  Fanconi anemia  * Immune deficiencies  * Mucopolysaccharidosis 7

Disease Status Case Report Forms  35 diseases  Type of Information  Diagnosis date  Current status  Best response to therapy  Form Builder Reports  Pre-Transplantation Disease Status Report: v1.0  Post-Transplantation Disease Status Report: v1.0 8

Progress Update  Recently released more than 600 CDEs  BRIDG  Majority of CDEs have been mapped to BRIDG  In the process of adding to the CDEs  Alternate names that indicate BRIDG class and attribute  Adding a reference document that indicates the BRIDG mapping path 9

Review Process  CDE  Automated error and validation reports  Peer  Technical  Subject matter expert  Form Builder  Automated comparison of question text and PVs in Form Builder and the CDE  Peer  Technical  Subject matter  Pre-release checklist 10

Appendix 11

Report Generation Tool  Custom-built application that generates reports based on CDE Browser XML  Performs some automated testing  Both template and custom designed reports 12

Report Generation Tool User Interface 13

Report Generation Tool Lookup Table 14

Report Generation Tool Error Report 15

Report Generation Tool Validation Report 16

Report Generation Tool Peer Report 17

Report Generation Tool Subject Matter Expert Review 18

Report Generation Tool Custom Reports 19

Disease Status CRFs Included Diseases  Acute Lymphoblastic Leukemia  Acute Myelogenous Leukemia  Amyloidosis  Breast Cancer  Central Nervous System Tumor  Chediak-Higashi Syndrome  Chronic Granulomatous Disease  Chronic Lymphocytic Leukemia  Chronic Myelogenous Leukemia  Congenital Amegakaryocytic Thrombocytopenia  Fanconi Anemia / Constitutional Anemia  Hemophagocytic Lymphohistiocytosis  Hepatitis Serology  Hodgkin and Non-Hodgkin Lymphoma  Human Immunodeficiency Virus  Juvenile Idiopathic Arthritis  Juvenile Myelomonocytic Leukemia  Langerhans Cell Histiocytosis  Leukodystrophies  Multiple Myeloma / Plasma Cell Leukemia  Multiple Sclerosis  Myelodysplasia / Myeloproliferative Disorders  Neuroblastoma  Osteopetrosis  Ovarian Cancer  Renal Carcinoma  Rheumatoid Arthritis  Sarcoma  Sickle Cell Anemia 20

Disease Status CRFs Included Diseases  Small Cell Lung Cancer  Systemic Lupus Erythematosus  Systemic Sclerosis  Testicular / Germ Cell Cancer  Waldenström's Macroglobulinemia  X-Linked Lymphoproliferative Syndrome 21